Submitted by medscape9178 in health
With the exception of venous thromboembolism and pulmonary embolism events, the antiviral drug did not reduce the incidence of post-COVID-19 conditions in a study of nearly 10,000 US veterans.
Comments
(._.)
There's nothing here…